BIOENVISION INC
10QSB, EX-27, 2000-11-17
NON-OPERATING ESTABLISHMENTS
Previous: BIOENVISION INC, 10QSB, 2000-11-17
Next: INFOCURE CORP, 10-Q/A, 2000-11-17



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-Mos
<FISCAL-YEAR-END>               JUN-30-2000
<PERIOD-END>                    SEP-30-2000
<CASH>                                         15
<SECURITIES>                                   0
<RECEIVABLES>                                  73,920
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               73,935
<PP&E>                                         52,023
<DEPRECIATION>                                 (13,058)
<TOTAL-ASSETS>                                 133,293
<CURRENT-LIABILITIES>                          1,664,647
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       28,652
<OTHER-SE>                                     (1,560,006)
<TOTAL-LIABILITY-AND-EQUITY>                   133,293
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               322,817
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,435
<INCOME-PRETAX>                                0
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (324,252)
<EPS-BASIC>                                    (0.04)
<EPS-DILUTED>                                  (0.04)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission